SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/80C7E14FC47C11670E8B3A166FE88123F04622529C6BC78C1BF596336E2A598D83085872D7EDD1DF91248A003B943877>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/80C7E14FC47C11670E8B3A166FE88123F04622529C6BC78C1BF596336E2A598D83085872D7EDD1DF91248A003B943877
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/80C7E14FC47C11670E8B3A166FE88123F04622529C6BC78C1BF596336E2A598D83085872D7EDD1DF91248A003B943877
http://www.w3.org/2000/01/rdf-schema#comment
"Expression levels of phosphorylated cdc25A (p-cdc25A) and phosphorylated Chk1 (p-Chk1) belonging to the ATR pathway were decreased by treatment with Dclk1 inhibitor LRRK2-IN-1 (LRRK) indicating Dclk1 involvement in the ATR pathway"
xsd:string
http://purl.uniprot.org/uniprot/#_DDF74F21283CEAE643DA89CD7072CB3BE4D7EB1928B47575F229AF2A292F50CFADCFC83D4C4D48B50BFF73EF67001F5A
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/80C7E14FC47C11670E8B3A166FE88123F04622529C6BC78C1BF596336E2A598D83085872D7EDD1DF91248A003B943877
http://purl.uniprot.org/uniprot/B7Z5K4
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/80C7E14FC47C11670E8B3A166FE88123F04622529C6BC78C1BF596336E2A598D83085872D7EDD1DF91248A003B943877
http://purl.uniprot.org/uniprot/#_B7Z5K4-mappedCitation-29048622
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/80C7E14FC47C11670E8B3A166FE88123F04622529C6BC78C1BF596336E2A598D83085872D7EDD1DF91248A003B943877